Natus Medical Stock Price, News & Analysis (NASDAQ:BABY)

$30.85 +0.75 (+2.49 %)
(As of 02/20/2018 10:19 AM ET)
Previous Close$30.85
Today's Range$30.15 - $30.90
52-Week Range$28.00 - $43.60
Volume370,700 shs
Average Volume723,081 shs
Market Capitalization$961.11 million
P/E Ratio-49.76
Dividend YieldN/A
Beta0.56

About Natus Medical (NASDAQ:BABY)

Natus Medical logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Debt-to-Equity Ratio0.37%
Current Ratio3.32%
Quick Ratio2.54%

Price-To-Earnings

Trailing P/E Ratio-49.7572619796455
Forward P/E Ratio18.93
P/E GrowthN/A

Sales & Book Value

Annual Sales$500.97 million
Price / Sales1.92
Cash Flow$2.16 per share
Price / Cash14.28
Book Value$13.55 per share
Price / Book2.28

Profitability

Trailing EPS($0.62)
Net Income$-20,290,000.00
Net Margins-4.05%
Return on Equity11.36%
Return on Assets6.96%

Miscellaneous

Employees1,160
Outstanding Shares31,150,000

Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) issued its quarterly earnings data on Wednesday, February, 7th. The medical equipment provider reported $0.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.54 by $0.12. The medical equipment provider had revenue of $131.40 million for the quarter, compared to analysts' expectations of $131.38 million. Natus Medical had a positive return on equity of 11.36% and a negative net margin of 4.05%. The business's revenue for the quarter was up 22.0% on a year-over-year basis. During the same period last year, the company posted $0.51 EPS. View Natus Medical's Earnings History.

When will Natus Medical make its next earnings announcement?

Natus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Natus Medical.

What guidance has Natus Medical issued on next quarter's earnings?

Natus Medical issued an update on its first quarter earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of $0.23-0.24 for the period, compared to the Thomson Reuters consensus estimate of $0.24. The company issued revenue guidance of $125-127 million, compared to the consensus revenue estimate of $123.91 million.

Where is Natus Medical's stock going? Where will Natus Medical's stock price be in 2018?

2 brokers have issued 12 month price targets for Natus Medical's stock. Their forecasts range from $49.00 to $49.00. On average, they anticipate Natus Medical's share price to reach $49.00 in the next twelve months. View Analyst Ratings for Natus Medical.

Are investors shorting Natus Medical?

Natus Medical saw a drop in short interest in the month of January. As of January 12th, there was short interest totalling 1,963,041 shares, a drop of 33.3% from the December 29th total of 2,945,067 shares. Based on an average daily trading volume, of 1,200,756 shares, the days-to-cover ratio is currently 1.6 days. Approximately 6.6% of the shares of the company are short sold.

Who are some of Natus Medical's key competitors?

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:

  • Robert A. Gunst, Independent Chairman of the Board (Age 67)
  • James B. Hawkins, President, Chief Executive Officer, Director (Age 61)
  • Jonathan A. Kennedy, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 46)
  • Leslie McDonnell, Vice President and General Manager - Newborn Care Business Unit
  • Austin F. Noll III, Vice President and General Manager - Neurology Strategic Business Unit (Age 50)
  • D. Christopher Chung M.D., Vice President - Medical Affairs, Quality & Regulatory (Age 53)
  • Doris E. Engibous, Independent Director (Age 62)
  • Kenneth E. Ludlum, Independent Director (Age 62)
  • William M. Moore Jr., Independent Director (Age 66)
  • Barbara R. Paul M.D., Independent Director (Age 63)

Who owns Natus Medical stock?

Natus Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.95%), Confluence Investment Management LLC (3.28%), Fisher Asset Management LLC (1.88%), Bank of New York Mellon Corp (1.49%), ArrowMark Colorado Holdings LLC (1.36%) and Rice Hall James & Associates LLC (1.33%). Company insiders that own Natus Medical stock include Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Kenneth M Traverso, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical.

Who sold Natus Medical stock? Who is selling Natus Medical stock?

Natus Medical's stock was sold by a variety of institutional investors in the last quarter, including Corsair Capital Management L.P., BlackRock Inc., Eagle Asset Management Inc., TIAA CREF Investment Management LLC, Bank of New York Mellon Corp, Olstein Capital Management L.P., Rice Hall James & Associates LLC and Confluence Investment Management LLC. Company insiders that have sold Natus Medical company stock in the last year include Dong Chune Christopher Chung, Doris Engibous, Robert A Gunst and William M Moore. View Insider Buying and Selling for Natus Medical.

Who bought Natus Medical stock? Who is buying Natus Medical stock?

Natus Medical's stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Cambiar Investors LLC, WCM Investment Management CA, Renaissance Technologies LLC, Deutsche Bank AG, Lyon Street Capital LLC, Wells Fargo & Company MN and Arizona State Retirement System. View Insider Buying and Selling for Natus Medical.

How do I buy Natus Medical stock?

Shares of Natus Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical's stock price today?

One share of Natus Medical stock can currently be purchased for approximately $30.85.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $961.11 million and generates $500.97 million in revenue each year. The medical equipment provider earns $-20,290,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis. Natus Medical employs 1,160 workers across the globe.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (BABY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  155 (Vote Outperform)
Underperform Votes:  143 (Vote Underperform)
Total Votes:  298
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Natus Medical (NASDAQ:BABY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.502.332.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $49.00$49.00$48.00$47.00
Price Target Upside: 69.26% upside69.26% upside37.14% upside34.29% upside

Natus Medical (NASDAQ:BABY) Consensus Price Target History

Price Target History for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ:BABY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/16/2018BenchmarkReiterated RatingBuy -> Buy$55.00 -> $49.00LowView Rating Details
1/8/2018William BlairDowngradeOutperform -> Market PerformHighView Rating Details
2/2/2017Raymond James FinancialDowngradeOutperform -> Market PerformN/AView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellN/AView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Natus Medical (NASDAQ:BABY) Earnings History and Estimates Chart

Earnings by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ BABY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018$0.28N/AView Earnings Details
2/7/2018Q4 2017$0.54$0.42$131.38 million$131.40 millionViewListenView Earnings Details
10/25/2017Q3 2017$0.38$0.40$122.41 million$122.60 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.33$0.34$121.99 million$122.20 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.33$0.30$122.45 million$124.70 millionViewN/AView Earnings Details
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.38$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
3/1/2011Q4 2010$0.22$0.24ViewN/AView Earnings Details
10/28/2010Q3 2010$0.19$0.17ViewN/AView Earnings Details
7/29/2010Q2 2010$0.14$0.15ViewN/AView Earnings Details
4/29/2010Q1 2010$0.03$0.09ViewN/AView Earnings Details
3/4/2010Q4 2009$0.15$0.15ViewN/AView Earnings Details
11/2/2009Q3 2009$0.11$0.14ViewN/AView Earnings Details
7/30/2009Q2 2009$0.05$0.08ViewN/AView Earnings Details
4/30/2009Q1 2009$0.03$0.03ViewN/AView Earnings Details
2/26/2009Q4 2008$0.21$0.22ViewN/AView Earnings Details
10/30/2008Q3 2008$0.18$0.17ViewN/AView Earnings Details
7/31/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
5/1/2008Q1 2008$0.10$0.11ViewN/AView Earnings Details
2/26/2008Q4 2007$0.18$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Natus Medical (NASDAQ:BABY) Earnings Estimates

2018 EPS Consensus Estimate: $2.09
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.38$0.38$0.38
Q2 20181$0.49$0.49$0.49
Q3 20181$0.51$0.51$0.51
Q4 20181$0.71$0.71$0.71
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Natus Medical (NASDAQ:BABY)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Natus Medical (NASDAQ BABY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 93.91%
Insider Trades by Quarter for Natus Medical (NASDAQ:BABY)
Insider Trades by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ BABY) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/13/2017William M MooreDirectorSell5,000$41.01$205,050.00View SEC Filing  
11/6/2017Dong Chune Christopher ChungVPSell12,642$42.91$542,468.22141,414View SEC Filing  
9/14/2017Robert A GunstDirectorSell4,400$35.17$154,748.0050,850View SEC Filing  
8/14/2017William M MooreDirectorSell3,000$34.10$102,300.0030,410View SEC Filing  
6/15/2017James B HawkinsInsiderBuy4,000$33.98$135,920.00578,023View SEC Filing  
5/31/2017James B. HawkinsInsiderBuy6,000$33.81$202,860.00View SEC Filing  
5/25/2017Doris EngibousDirectorSell5,000$32.68$163,400.0022,650View SEC Filing  
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.0056,150View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00477,396View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00469,725View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.4091,351View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.1891,351View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.0051,150View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00459,725View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.0055,000View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.0018,250View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04112,119View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.5080,325View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00123,043View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99377,274View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.0057,934View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18434,785View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00477,274View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00123,043View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.7674,000View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.4421,910View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.0021,910View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.5421,910View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.0021,910View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00468,844View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42468,844View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30468,844View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24413,844View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.506,000View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04120,972View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20413,211View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Natus Medical (NASDAQ BABY) News Headlines

Source:
DateHeadline
Natus Medical Inc to Post FY2018 Earnings of $1.63 Per Share, William Blair Forecasts (BABY)Natus Medical Inc to Post FY2018 Earnings of $1.63 Per Share, William Blair Forecasts (BABY)
www.americanbankingnews.com - February 12 at 6:54 AM
Natus Medical Hears a Rebound ComingNatus Medical Hears a Rebound Coming
finance.yahoo.com - February 10 at 9:37 AM
Free Post Earnings Research Report: Zimmer Biomet’s Quarterly Sales Grew 3%; Topped ExpectationsFree Post Earnings Research Report: Zimmer Biomet’s Quarterly Sales Grew 3%; Topped Expectations
finance.yahoo.com - February 9 at 9:40 AM
Why Natus Medical Incorporated Stock Lost 19% in JanuaryWhy Natus Medical Incorporated Stock Lost 19% in January
finance.yahoo.com - February 8 at 3:41 PM
Natus Medical Announces Fourth Quarter and Full Year 2017 Financial ResultsNatus Medical Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - February 7 at 9:26 AM
Natus Medical Incorporated to Host Earnings CallNatus Medical Incorporated to Host Earnings Call
finance.yahoo.com - February 7 at 9:26 AM
Does Natus Medical Incorporated’s (NASDAQ:BABY) Past Performance Indicate A Weaker Future?Does Natus Medical Incorporated’s (NASDAQ:BABY) Past Performance Indicate A Weaker Future?
finance.yahoo.com - February 7 at 9:26 AM
Natus Medical reports 4Q lossNatus Medical reports 4Q loss
finance.yahoo.com - February 7 at 9:26 AM
Natus Medical (BABY) Issues Q1 Earnings GuidanceNatus Medical (BABY) Issues Q1 Earnings Guidance
www.americanbankingnews.com - February 7 at 9:10 AM
Natus Medical (BABY) Announces Quarterly  Earnings ResultsNatus Medical (BABY) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 7 at 9:02 AM
Natus Medical (BABY) to Release Quarterly Earnings on WednesdayNatus Medical (BABY) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 31 at 3:56 AM
Natus Medical Inc (BABY) Short Interest UpdateNatus Medical Inc (BABY) Short Interest Update
www.americanbankingnews.com - January 28 at 1:26 AM
Financial Comparison: Natus Medical (BABY) vs. Accuray (ARAY)Financial Comparison: Natus Medical (BABY) vs. Accuray (ARAY)
www.americanbankingnews.com - January 21 at 7:22 PM
Natus Medical Inc (BABY) Given Consensus Rating of "Hold" by AnalystsNatus Medical Inc (BABY) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - January 20 at 12:02 AM
Detailed Research: Economic Perspectives on Basic Energy Services, Intercept Pharmaceuticals, Natus Medical, Surmodics, EnviroStarm, and Nicolet Bankshares — What Drives Growth in Todays Competitive LandscapeDetailed Research: Economic Perspectives on Basic Energy Services, Intercept Pharmaceuticals, Natus Medical, Surmodics, EnviroStarm, and Nicolet Bankshares — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - January 19 at 12:22 PM
Natus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on February 7thNatus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on February 7th
finance.yahoo.com - January 17 at 11:17 AM
Benchmark Lowers Natus Medical (BABY) Price Target to $49.00Benchmark Lowers Natus Medical (BABY) Price Target to $49.00
www.americanbankingnews.com - January 16 at 12:44 PM
Bear of the Day: Natus Medical (BABY)Bear of the Day: Natus Medical (BABY)
finance.yahoo.com - January 16 at 11:26 AM
Natus Medical (BABY) Downgraded by Zacks Investment ResearchNatus Medical (BABY) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 11 at 7:08 PM
Natus Medical Inc. (BABY) Is Losing Ground On Q1 ForecastNatus Medical Inc. (BABY) Is Losing Ground On Q1 Forecast
www.nasdaq.com - January 8 at 3:45 PM
Why Natus Medical Inc Sank Lower TodayWhy Natus Medical Inc Sank Lower Today
finance.yahoo.com - January 8 at 3:45 PM
Form 8-K NATUS MEDICAL INC For: Jan 08 - StreetInsider.comForm 8-K NATUS MEDICAL INC For: Jan 08 - StreetInsider.com
www.streetinsider.com - January 8 at 8:36 AM
Natus Medical Announces 2018 Annual and First Quarter Financial GuidanceNatus Medical Announces 2018 Annual and First Quarter Financial Guidance
finance.yahoo.com - January 8 at 8:36 AM
$145.85 Million in Sales Expected for Natus Medical Inc (BABY) This Quarter$145.85 Million in Sales Expected for Natus Medical Inc (BABY) This Quarter
www.americanbankingnews.com - January 7 at 6:26 PM
Natus Medical (BABY) Stock Rating Lowered by BidaskClubNatus Medical (BABY) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - January 6 at 8:10 PM
Natus Medical (BABY) Shares Cross Below 200 DMANatus Medical (BABY) Shares Cross Below 200 DMA
www.nasdaq.com - January 4 at 11:12 AM
Natus Medical (BABY) Downgraded by Zacks Investment Research to HoldNatus Medical (BABY) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - December 26 at 10:36 PM
ETFs with exposure to Natus Medical, Inc. : December 26, 2017ETFs with exposure to Natus Medical, Inc. : December 26, 2017
finance.yahoo.com - December 26 at 12:39 PM
Natus Medical Inc (BABY) Receives Average Rating of "Hold" from AnalystsNatus Medical Inc (BABY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 26 at 12:06 AM
Natus Medical, Inc. :BABY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017Natus Medical, Inc. :BABY-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:19 PM
Natus Medical Inc (BABY) Expected to Announce Quarterly Sales of $145.85 MillionNatus Medical Inc (BABY) Expected to Announce Quarterly Sales of $145.85 Million
www.americanbankingnews.com - December 21 at 2:02 PM
Natus Medical Shows Improved Relative Strength; Still Shy Of BenchmarkNatus Medical Shows Improved Relative Strength; Still Shy Of Benchmark
finance.yahoo.com - December 20 at 11:26 AM
Natus Medical, Inc. is trading above its 50 day moving average : BABY-US : December 20, 2017Natus Medical, Inc. is trading above its 50 day moving average : BABY-US : December 20, 2017
finance.yahoo.com - December 20 at 11:26 AM
4 Growth Stocks to Pick From a Choppy MedTech Market - Nasdaq4 Growth Stocks to Pick From a Choppy MedTech Market - Nasdaq
www.nasdaq.com - December 14 at 11:33 AM
4 Growth Stocks to Pick From a Choppy MedTech Market4 Growth Stocks to Pick From a Choppy MedTech Market
finance.yahoo.com - December 14 at 11:33 AM
Natus to Present at J.P. Morgan 36th Annual Healthcare Conference ... - GlobeNewswire (press release)Natus to Present at J.P. Morgan 36th Annual Healthcare Conference ... - GlobeNewswire (press release)
globenewswire.com - December 13 at 3:42 PM
Natus to Present at J.P. Morgan 36th Annual Healthcare ConferenceNatus to Present at J.P. Morgan 36th Annual Healthcare Conference
finance.yahoo.com - December 13 at 11:44 AM
Natus Medical (BABY) Downgraded by BidaskClub to "Sell"Natus Medical (BABY) Downgraded by BidaskClub to "Sell"
www.americanbankingnews.com - December 9 at 10:36 AM
 Brokerages Expect Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 Million Brokerages Expect Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 Million
www.americanbankingnews.com - December 3 at 6:26 AM
Stocks With Rising Relative Strength: Natus MedicalStocks With Rising Relative Strength: Natus Medical
finance.yahoo.com - December 1 at 6:31 PM
Natus Medical Incorporated (BABY) Given Average Rating of "Hold" by AnalystsNatus Medical Incorporated (BABY) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 30 at 11:48 PM
Earnings Review and Free Research Report: Natus Medical’s Revenue Soared 34.9%Earnings Review and Free Research Report: Natus Medical’s Revenue Soared 34.9%
finance.yahoo.com - November 22 at 5:02 PM
Natus Medical, Inc. – Value Analysis (NASDAQ:BABY) : November 17, 2017Natus Medical, Inc. – Value Analysis (NASDAQ:BABY) : November 17, 2017
finance.yahoo.com - November 17 at 4:03 PM
Natus Medical (BABY) Presents At Stifel 2017 Healthcare Conference - SlideshowNatus Medical (BABY) Presents At Stifel 2017 Healthcare Conference - Slideshow
seekingalpha.com - November 16 at 4:37 PM
Natus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : November 16, 2017Natus Medical, Inc. breached its 50 day moving average in a Bearish Manner : BABY-US : November 16, 2017
finance.yahoo.com - November 16 at 9:04 AM
Natus Medical Incorporated (BABY) Director William M. Moore Sells 5,000 SharesNatus Medical Incorporated (BABY) Director William M. Moore Sells 5,000 Shares
www.americanbankingnews.com - November 15 at 8:44 PM
Zacks.com highlights: Natus Medical, GoPro, Enviva Partners and BrukerZacks.com highlights: Natus Medical, GoPro, Enviva Partners and Bruker
finance.yahoo.com - November 15 at 3:17 PM
4 Top Stocks With Earnings Acceleration to Buy Now4 Top Stocks With Earnings Acceleration to Buy Now
finance.yahoo.com - November 14 at 4:46 PM
Zacks: Analysts Anticipate Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 MillionZacks: Analysts Anticipate Natus Medical Incorporated (BABY) Will Announce Quarterly Sales of $145.85 Million
www.americanbankingnews.com - November 14 at 3:56 AM
 Brokerages Anticipate Natus Medical Incorporated (BABY) Will Post Earnings of $0.71 Per Share Brokerages Anticipate Natus Medical Incorporated (BABY) Will Post Earnings of $0.71 Per Share
www.americanbankingnews.com - November 12 at 10:04 PM

SEC Filings

Natus Medical (NASDAQ:BABY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Natus Medical (NASDAQ:BABY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Natus Medical (NASDAQ BABY) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.